This inventor holds 1 USPTO granted patent and 6 published patent applications. Top assignee: Frontier Medicines Corporation. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Philip A. Gerken: Innovator in Cancer Treatment
Introduction
Philip A. Gerken is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of cancer treatment through his innovative research and development of pharmaceutical compounds. His work focuses on addressing specific cancer types characterized by the KRAS G12C mutation.
Latest Patents
Philip A. Gerken holds 1 patent related to KRAS G12C inhibitors. This patent provides compounds and methods that are useful in the treatment and suppression of cancer. The compounds are specifically designed to target cancers characterized by the KRAS G12C mutation. Additionally, the patent includes pharmaceutical compositions containing these compounds and outlines processes for their preparation.
Career Highlights
Gerken is currently associated with Frontier Medicines Corporation, where he continues to advance his research in cancer therapeutics. His work at Frontier Medicines Corporation emphasizes the development of innovative solutions for challenging cancer types.
Collaborations
Some of his notable coworkers include Snahel Patel and Monika Jane Williams, who contribute to the collaborative efforts in research and development at Frontier Medicines Corporation.
Conclusion
Philip A. Gerken's contributions to cancer treatment through his innovative patents and collaborative work highlight his commitment to advancing medical science. His research continues to pave the way for new therapeutic options for patients suffering from cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile